How your customers see you

April 6, 2004

When looking at the performance of new products there are many reasons for their possible success. Perhaps GPs hooked into …

Amgen pipeline boosted by $1.3bn Tularik acquisition

April 5, 2004

US biotech Amgen is to buy gene regulation specialist Tularik in a move that will add five drug candidates to …

US accused of blocking generics AIDS drug plan

April 5, 2004

Aid agencies are claiming that plans to provide antiretroviral treatment for millions of people with HIV are being undermined by …

Size isn’t everything

March 30, 2004

Pharmaceutical company sales teams have grown significantly in size over the last few years the – figures vary, but by …

New antidepressant warnings in US and Britain

March 25, 2004

New warnings about the prescribing of the Selective Serotonin Reuptake Inhibitor (SSRI) class of antidepressants have been issued in the …

Bayer feels cost of restructuring

March 25, 2004

German pharmaceutical company Bayer has posted the biggest losses in its history after paying a hefty price for restructuring the …

Solvay and Altana to swap detailing time

March 25, 2004

Altana Pharma and Solvay Healthcare are to launch a novel 'time-swap' co-promotional agreement to make the most of their salesforces' …

France pours cold water on Novartis talks

March 25, 2004

Merger talks between Swiss pharma company Novartis and Franco-German Aventis could be in jeopardy after the French government indicated its …

New code for journals in wake of MMR conflict of interest

March 19, 2004
MMR, journals

A new code of conduct has been drawn up for medical journals to help uncover conflicts of interest which could …

UK and US face up to public health crises

March 19, 2004

The UK government has launched a consultation that it hopes will stimulate debate on how best to tackle the growing …

The Gateway to Local Adoption Series

Latest content